作为PGC-1α转录激活剂的ZLN005,在永久性闭塞模型中,在心肌梗塞后加剧心脏功能
Taiga Okumura1, Takahiro Sasaki1, Yoshiki Kuse1
1Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
Biochemical and biophysical research communications
|August 1, 2025
概括
作为PGC-1α激活剂的ZLN005,通过降低心脏功能和线粒体ATP产生,恶化了心肌梗塞 (MI) 的结果. 这项研究表明,持续服用ZLN005会加剧心脏病发作.
科学领域:
- 心脏病学 心脏病学
- 线粒体生物学 线粒体生物学
- 分子医学是分子医学.
背景情况:
- 缺血性心脏病,特别是心肌梗塞 (MI),是全球主要的死亡原因.
- 在25%的患者中,急性MI导致心力衰竭,心肌线粒体功能障碍有助于心脏重塑.
- 线粒体对于心肌ATP的产生至关重要,受过氧酶增殖器激活受体玛协活性剂1α (PGC-1α) 的调节.
研究的目的:
- 用体内和体外模型研究ZLN005,一种PGC-1α激活剂对心肌梗塞 (MI) 的影响.
- 为了确定使用ZLN005激活PGC-1α是否会改善或加重MI引起的心脏功能障碍.
主要方法:
- 在体内研究涉及诱导小鼠的MI并用ZLN005治疗它们14天.
- 在体外研究中使用了接受氧气-葡萄糖剥夺并用ZLN005.5治疗的心肌细胞.
- 评估方法包括测量PGC-1α表达,BAX/Bcl-2比率,通过心电图测量心脏功能,以及线粒体功能/ATP产生.
主要成果:
- 在小鼠中,PGC-1α表达在MI后7天显著下降.
- 治疗ZLN005增加了BAX/Bcl-2比率,表明细胞死亡增加.
- 在体内和体外模型中,ZLN005的使用导致心脏功能下降和线粒体ATP生产受损.
结论:
- 持续使用ZLN005会加剧心肌梗塞 (MI) 的发病性.
- 在缺血条件下使用ZLN005激活PGC-1α对心脏功能和线粒体健康有害.
- 这些发现突显了PGC-1α激活剂在心脏病发作中的潜在风险.
更多相关视频
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
6.2K
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.6K
相关概念视频
G-Protein Gated Ion Channels
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
